• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Remus Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 78788.0
  • ISIN : INE0O5T01011
894.45 -26 (-2.83%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    890.00

  • Today’s High

    906.00

  • Open

    893.50

  • Perv Close

    920.50

  • 52W Low

    870.00

  • 52W High

    1,417.38

Key Indicators

  • P/E(TTM)

    52.96

  • Mar.Cap (₹Cr.)

    1,054.02

  • Div & Yield %

    0.00

  • Book Value(₹)

    205.55

  • Debt-Equity Ratio

    -2.83

  • AGM Date

    01-Aug-2025

  • EPS

    16.89

  • P/E Ratio

    52.96

Financials Ratios

  • Debt-Equity Ratio

    0.13

  • Mar.Cap (₹Cr.)

    1,054.02

  • RONW (%)

    29.91

  • ROCE (%)

    32.68

Score Board

  • Equity (₹ in Cr.)

    11.78

  • BV (₹)

    205.60

  • Sales( ₹ in Cr.)

    79.16

  • NP (in Cr.)

    19.90

  • NP Var(%)

    18.0

  • Div%

    0.0

  • CPS (₹)

    18.50

  • EPS (₹)

    16.90

  • Traded Value (₹ in Lakhs)

    1,054.02

  • 52 Week High

    1,417.38

  • 52 Week Low

    870.00

  • Price BSE

    0.0

  • Price NSE

    894.00

  • Market Capital( in Cr.)

    1,054.02

  • P/C Ratio

    48.40

  • P/E Ratio

    52.90

  • Price Vs.BV

    16.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 63.50 45.03 24.72 18.42 11.92 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 63.50 45.03 24.72 18.42 11.92 -
Other Income 3.69 1.58 0.72 0.81 0.85 -
Stock Adjustments 1.38 -1.30 0.44 0.71 0.40 -
Total Income 68.57 45.31 25.88 19.94 13.17 -
EXPENDITURE :            
Raw Materials 29.21 20.14 12.71 12.21 7.44 -
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.01 -
Employee Cost 6.56 5.47 3.42 2.95 2.86 -
Other Manufacturing Expenses 5.33 4.57 2.02 0.00 0.26 -
Selling and Administration Expenses 3.55 2.98 2.70 0.00 1.37 -
Miscellaneous Expenses 0.18 0.02 0.17 3.17 0.00 -
Employee Benefit Expenses 6.56 5.47 3.42 2.95 2.86 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 44.83 33.18 21.02 18.33 11.93 -
Operating Profit 23.74 12.12 4.86 1.61 1.24 -
Interest 0.32 0.23 0.09 0.03 0.04 -
Gross Profit 23.42 11.89 4.77 1.58 1.20 -
Depreciation 0.90 0.48 0.15 0.18 0.11 -
Profit Before Tax 22.52 11.41 4.62 1.40 1.09 -
Current Tax 6.42 3.00 1.19 0.37 0.31 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax -0.71 -0.09 -0.01 -0.02 -0.02 -
Reported Net Profit 16.82 8.50 3.43 1.06 0.81 -
Extraordinary Items 0.01 0.00 0.01 0.08 0.00 -
Adjusted Net Profit 16.81 8.50 3.42 0.98 0.81 -
Adjustment below Net Profit 0.00 -0.20 -0.99 0.00 0.00 -
P & L Balance brought forward 13.89 5.58 3.13 2.07 1.20 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.59 0.00 0.00 0.00 0.00 -
P & L Balance carried down 30.12 13.89 5.58 3.13 2.01 -
Dividend 0.59 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 20.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 2.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 114.19 78.37 34.34 1,059.50 811.60 -
Earnings Per Share(Adj)-Unit Curr 14.27 - - - - -
Book Value 557.11 176.36 65.78 3,143.70 2,020.30 -
Book Value(Adj)-Unit Curr 69.64 - - - - -

Shareholding Pattern

  • Promoter Group

    70.85%

  • Public Share Holding

    29.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 107,800 0.91 107,800 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,241,700 69.94 8,241,700 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,349,500 70.85 8,349,500 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 592,800 5.03 592,800 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 93,200 0.79 93,200 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 686,000 5.82 686,000 6
2] Non Institution
Bodies Corporate 143,800 1.22 143,800 33
Clearing Members 0 0.00 0 0
Directors of their Relatives 16,000 0.14 16,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 21,600 0.18 21,600 45
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 308,000 2.61 308,000 137
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 866,200 7.35 866,200 17
Individuals holding nominal share capital up to Rs. 1 lakh 1,360,400 11.54 1,360,400 1,760
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,600 0.01 1,600 1
Sub Total 2,748,500 23.32 2,748,500 2,002
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,784,000 100.00 11,784,000 2,017

Company Background

Remus Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Remus Pharmaceuticals Ltd
  • BSE Code : 78788.0
  • ISIN : INE0O5T01011

  • Incorporation Year

    2015

  • Registered Office

    1101 to 1103 South Tower One42
    B/H Ashok Vatika Amblibopal Rd, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-079-29999857

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    Parikh & Majmudar/Pankaj R Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Remus Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Remus Pharma. 894.45 67.19 63.50 52.96 41.05
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10